0.06Open0.06Pre Close0 Volume27 Open Interest25.00Strike Price0.00Turnover117.06%IV22.60%PremiumJul 26, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type0.0583Delta0.0463Gamma340.67Leverage Ratio-0.0321Theta0.0001Rho19.85Eff Leverage0.0025Vega
TG Therapeutics Stock Discussion
$AGBA Group(AGBA.US)$
$TG Therapeutics(TGTX.US)$
The company said fourth quarter loss narrowed to 9 cents a share from 39 cents a year earlier. That's smaller than the 11 cents expected by analysts polled by Capital IQ, according to MT Newswires.
Revenue for the three months ende...
No comment yet